Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | G466X |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | BRAF G466X indicates any BRAF missense mutation that results in replacement of the glycine (G) at amino acid 466 by a different amino acid. |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF G466X |
Transcript | NM_004333.6 |
gDNA | chr7:g.140781610_140781612 |
cDNA | c.1396_1398 |
Protein | p.G466 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001378471.1 | chr7:g.140777999_140778001 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
NM_001378472.1 | chr7:g.140777052_140777054 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
XM_047420766.1 | chr7:g.140778074_140781576 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
XM_047420769.1 | chr7:g.140781610_140781612 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140781610_140781612 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
NM_004333.5 | chr7:g.140781610_140781612 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140781610_140781612 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140781610_140781612 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
NM_001378473.1 | chr7:g.140777052_140777054 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140781610_140781612 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140781610_140781612 | c.1396_1398 | p.G466 | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03839342 | Phase II | Binimetinib + Encorafenib | Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations (BEAVER) | Active, not recruiting | CAN | 0 |